Trial to see effectiveness Of Nasal Administration of Vacha Pippali Oil and oral medication in Ardhavbhedak wsr Migraine

An Open Label Randomized Controlled clinical trial of Vacha Pippali Tail Nasya and Pathyadi Kwath in Ardhavbhedak w.s.r Migraine

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/02/049845

Enrollment

300

Registered

2023-02-20

Start date

Unknown

Completion date

Unknown

Last updated

2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G430- Migraine without aura

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age group- 15-50 years unilateral headache with moderate or severe intensity causing avoidance of routine physical activity lasting 4-72 hours associated with nausea/or vommiting photophobia/phonophobia

Exclusion criteria

Exclusion criteria: secondary headache systemic/metabolic disorder

Design outcomes

Primary

Measure	Time frame
Significant improvement in- MIDAS HIT-6Timepoint: 45 days of therapy	—

Secondary

Measure	Time frame
Improvement in Headache and quality of life Timepoint: Every 15 days interval for two months after completion of therapy	—

Countries

India

Contacts

Public ContactPoonam Bamola

parul university

manjirikeskar@gmail.com9822606358

Outcome results